Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAB11FIP2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DOCK11 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
TAX1BP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
NIN - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
DNAJC10 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
NAB1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
CAMSAP2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
CFI - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ZNF518B - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
RNGTT - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Profile neighbors
PPP1R8 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
VMA21 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
PYGO1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
RFC1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
YIPF1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
IL6ST - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
MYO1B - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
VCPIP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
STAT1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on